Acute hepatitis C has a high propensity to become chronic, which provides the rationale for treating patients with acute disease attempting to prevent chronicity. Almost all published studies on therapy of acute hepatitis C have been small in size, uncontrolled, and highly heterogeneous as to patien
Therapy of acute hepatitis C
✍ Scribed by Alfredo Alberti; Silvia Boccato; Alessandro Vario; Luisa Benvegnù
- Book ID
- 111722057
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 125 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Early treatment of acute hepatitis C infection with interferon alfa-2b (IFN -␣-2b) prevents chronicity in almost all patients. So far, no data are available on the long-term outcome after interferon (IFN) therapy of acute hepatitis C. The aim of this study was to assess the clinical, virologica
To test whether interferon can prevent acute non-A, non-B hepatitis from becoming chronic, a prospective controlled trial was conducted in 26 patients; 11 were treated for an average of 30 days with a mean of 52 megaunits of interferon and 14 acted as controls. 4 patients in the treatment group who